Background Oral mucositis is a side effect of chemotherapy, head and neck radiotherapy,
and targeted therapy, affecting over 75% of high‐risk patients. Ulceration can lead to severe …

Background Treatment of cancer is increasingly more effective but is associated with short
and long term side effects. Oral side effects remain a major source of illness despite the use …

Purpose To update the clinical practice guidelines for the use of growth factors and
cytokines for the prevention and/or treatment of oral mucositis (OM). Methods A systematic …

Goals of work Growth factors and cytokines may be useful in preventing chemotherapy (CT)-
and radiotherapy (RT)-induced oral and gastrointestinal mucositis. Two systematic reviews …

Oral mucositis is a common and most debilitating complication associated with cancer
therapy. Despite the significant clinical and economic impact of this condition, there is little to …

Patients with oral mucositis (OM) have inflamed epithelial lesions of the mouth that progress
to form painful ulcerations with submucosal hemorrhaging and infection. Oral mucositis …

Purpose The aim of this project was to review the literature and define clinical practice
guidelines for the use of cytokines and growth factor agents for the prevention or treatment of …

Purpose The aim of this project was to review the available literature and define clinical
practice guidelines for the use of anti-inflammatory agents for the prevention and treatment …

The Multinational Association of Supportive Care in Cancer/International Society of Oral
Oncology (MASCC/ISOO) is a partnership between two professional organizations focusing …

Objective To examine the comparative efficacy and safety of interventions for preventing
chemotherapy-induced oral mucositis (OM) in adult cancer patients. Methods We searched …